Your browser doesn't support javascript.
loading
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas.
Christensen, Paul A; Olsen, Randall J; Long, S Wesley; Snehal, Richard; Davis, James J; Ojeda Saavedra, Matthew; Reppond, Kristina; Shyer, Madison N; Cambric, Jessica; Gadd, Ryan; Thakur, Rashi M; Batajoo, Akanksha; Mangham, Regan; Pena, Sindy; Trinh, Trina; Kinskey, Jacob C; Williams, Guy; Olson, Robert; Gollihar, Jimmy; Musser, James M.
Afiliação
  • Christensen PA; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas; Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomi
  • Olsen RJ; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas; Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomi
  • Long SW; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas; Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomi
  • Snehal R; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Davis JJ; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois; Computing, Environment and Life Sciences, Argonne National Laboratory, Lemont, Illinois.
  • Ojeda Saavedra M; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Reppond K; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Shyer MN; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Cambric J; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Gadd R; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Thakur RM; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Batajoo A; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Mangham R; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Pena S; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Trinh T; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Kinskey JC; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Williams G; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas.
  • Olson R; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois; Computing, Environment and Life Sciences, Argonne National Laboratory, Lemont, Illinois.
  • Gollihar J; Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.
  • Musser JM; Laboratory of Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston, Texas; Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomi
Am J Pathol ; 192(4): 642-652, 2022 04.
Article em En | MEDLINE | ID: mdl-35123975
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Am J Pathol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Am J Pathol Ano de publicação: 2022 Tipo de documento: Article